The TCR Vβ repertoire usage of T-cells from cord blood induced by chronic myelogenous leukemia associated antigen

Hematology

Volumn 10, Issue 5, 2005, Pages 387-392

  Li, Yangqiu ^a   Yang, Lijian ^a   Chen, Shaohua ^a   Zhang, Yuping ^a   Wu, Xiuli ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

CML; Cord blood; Leukemia associated antigen; Mix lymphocytes; T cell clonal expansion; TCR V repertoire; Tumor cells culture

Indexed keywords

BCR ABL PROTEIN; CD3 ANTIBODY; INTERLEUKIN 2; LEUKEMIA ANTIGEN; PHYTOHEMAGGLUTININ; T LYMPHOCYTE RECEPTOR BETA CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; CELL CLONE; CELL CULTURE; CHRONIC MYELOID LEUKEMIA; CLONAL VARIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; IN VITRO STUDY; LEUKEMIA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; UMBILICAL CORD BLOOD; CELL PROLIFERATION; CELL STRAIN K 562; COCULTURE; COMPLEMENTARITY DETERMINING REGION; CYTOLOGY; FEMALE; FETUS BLOOD; GENE REARRANGEMENT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE;

CELL PROLIFERATION; COCULTURE TECHNIQUES; COMPLEMENTARITY DETERMINING REGIONS; FEMALE; FETAL BLOOD; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; K562 CELLS; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTE ACTIVATION; MALE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 29144462172     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330500226662     Document Type: Article

References (32)

1. Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995;16:176-181.
2. Romero P, Cerottinl JC, Waanders GA. Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy. Mol Med Today 1998;4:305-312.
3. 2a cells. Blood 2001;99(11):122a.
4. Serrano D, Monteiro J, Allen SL, Kolitz J, Schulman P, Lichtman SM, Buchbinder A, Vinciguerra VP, Chiorazzi N, Gregersen PK. Clonal expansion within the CD4+CD57+ and CD8+CD57+T cell subsets in chronic lymphocytic leukemia. J Immunol 1997;158:1482-1489.
5. Rezvany MR, Jeddi-Tehrani M, Osterborg A, Kimby E, Wigzell H, Mellstedt H. Oligoclonal TCR BV gene usage in B-cell chronic lymphocytic leukemia: Major perturbations are preferentially seen within the CD4 T-cell subset. Blood 1999;94:1063-1069.
6. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995;346:214-219.
7. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK, McGlave PB, Sender L, Cairo MS. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease. Blood 1996;88:795-802.
8. Garderet L, Dulphy N, Douay C, Chalumeau N, Schaeffer V, Zilber MT, Lim A, Even J, Mooney N, Gelin C, Gluckman E, Charron D, Toubert A. The umbilical cord blood alphabeta T-cell repertoire: Characteristics of a polyclonal and naive but completely formed repertoire. Blood 1998;91:340-346.
9. Toubert A, Douay C, Chalumeau N, Garderet L, Dulphy N, Zilber MT, Gelin C, Mooney N, Charron D. Effects of superantigenic stimulation on the cord blood alphabeta T cell repertoire. Bone Marrow Transplant 1998;22(Suppl. 1): S36-S38.
10. Koyama S. Augmented human tumor cytolytic activity of peripheral blood lymphocytes and cells from a mixed lymphocyte/tumor culture activated by interleukin-12 plus interleukin-2, and the phenotypic characterization of the cells in patients with advanced carcinoma. J Cancer Res Clin Oncol 1997;123:478-484.
11. Meij P, Bloemena E, Palmen N, Brink A, Vervoort MB, Meijer CJ, Middeldorp JM. Functional CD4+ and CD8+T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines. Cell Immunol 2001;208:25-33.
12. Yotnda P, Firat H, Garcia-Pons F, Garcia Z, Gourru G, Vernant JP, Lemonnier FA, Leblond V, Langlade-Demoyen P. Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia. J Clin Invest 1998;101:2290-2296.
13. +T lymphocytes respond to dendritic cells pulsed with b3a2 peptide and antigen-presenting cells exposed to b3a2 containing cell lysates. Blood 1997;90:290-297.
14. Tanaka F, Fujie T, Go H, Baba K, Mori M, Takesako K, Akiyoshi T. Efficient induction of antitumor cytotoxic T lymphocytes from a healthy donor using HLA-A2-restricted MAGE-3 peptide in vitro. Cancer Immunol Immunother 1997;44:21-26.
15. Puisieux I, Even J, Pannetier C, Jotereau F, Favrot M, Kourilsky P. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol 1994;153:2807-2818.
16. Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: The T cell equivalent to "benign monoclonal gammapathy". J Exp Med 1994;179:609-618.
17. van den Beemd R, Boor PP, van Lochern EG, Hop WC, Langerak AW, Wolvers-Tettero IL, Hooijkaas H, van Dongen JJ. Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 2000;40:336-345.
18. Alfani E, Migliaccio AR, Sanchez M, Passarelli AM, Migliaccio G. Characterization of the T cell receptor repertoire of neonatal T cells by RT-PCR and single strand conformation polymorphism analysis. Bone Marrow Transplant 2000;26:83-89.
19. Marolleau JP, Ternaux B, Dal Cortivo L, Brossard Y, Gluckman E, Benbunan M. T cell repertoire of human umbilical cord blood. Bone Marrow Transplant 1998;22(Suppl 1):S39-S40.
20. Rezvany MR, Jeddi-Tehrani M, Wigzell H, Osterborg A, Mellstedt H. Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia. Blood 2003;101:1063-1070.
21. Heike M, Duchmann R, May E, Schulze-Bergkamen H, Schmitt U. Meyer zum Buschenfelde KH. Dominant TCRB-V-J chain usage and clonal expansion of sarcoma-reactive CD4+ HLA-DR-restricted T cells suggest a limited set of immunodominant sarcoma antigens. Int J Cancer 1997;72:403-407.
22. Jahn B, Bergmann L, Weidmann E, Brieger J, Fenchel K, Schwulera U, Hoelzer D, Mitrou PS. Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autoulogous cytotoxicity. Leuk Res 1995;19:73-82.
23. Li Y. Leukemia associated clonal expansion TCR Vβ subfamily T cells. Hematology 2003;8:375-384.
24. Orsini E, Alyea EP, Schlossman R, Canning C, Soiffer RJ, Chillemi A, Neuberg D. Chaanges in T cell receptor repertoire associated with graf-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion. Bone Marrow Transplant 2000;25: 623-632.
25. Claret EJ, Alyea EP, Orsini E, Pickett CC, Collins H, Wang Y, Neuberg D, Soiffer RJ, Ritz J. Charaterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion. J Clin Invest 1997;100:855-866.
26. Jurickova I, Waller EK, Yeager AM, Boyer MW. Generation of alloreactive anti-leukemic cytotoxic T lymphocytes with attenuated GVHD properties from haploidentical parents in childhood acute lymphoblastic leukemia. Bone Marrow Transplant 2002;30:687-697.
27. Currier JR, Deulofeut H, Barron KS, Kehn PJ, Robinson MA. Mitogens, superantigens, and nominal antigens elicit distinctive patterns of TCRB CDR3 diversity. Hum Immunol 1996;48:39-51.
28. Osman Y, Takahashi M, Zheng Z, Toba K, Liu A, Furukawa T, Narita M, Aizawa Y, Koike T, Shibata A. Dendritic cells stimulate the expansion of PML-RAR alpha specific cytotoxic T-lymphocytes: Its applicability for antileukemia immunotherapy. J Exp Clin Cancer Res 1999;18:485-492.
29. Maeda M, Otsuka T, Kimura N, Kozu T, Fukuyama T, Uchida N, Sugio Y, Itoh Y, Iino T, Inaba S, Niho Y. Induction of MTG8-specific cytotoxic T-cell lines: MTG8 is probably a tumour antigen that is recognized by cytotoxic T cells in AML1-MTG8-fused gene-positive acute myelogenous leukaemia. Br J Haematol 2000;111:570-579.
30. Azuma T, Makita M, Ninomiya K, Fujita S, Harada M, Yasukawa M. Identification of a novel WT1-derived peptide which induces human leucocyte antigen-A24-restricted anti-leukaemia cytotoxic T lymphocytes. Br J Haematol 2002; 116:601-603.
31. Hoffmann TK, Loftus DJ, Nakano K, Maeurer MJ, Chikamatsu K, Appella E, Whiteside TL, De Leo AB. The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53(264-272) epitope. J Immunol 2002;168:1338-1347.
32. Bocchia M, Korontsvit T, Xu Q, Mackinnon S, Yang SY, Sette A, Scheinberg DA. Specific human cellular immunity to BCR-ABL oncogene-derived peptides. Blood 1996;87:3587-3592.